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dard fermentation conditions. This review focuses on the effects of biological (co-cultivation), chemical, aswell as
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and exempliﬁes the diversity of natural products that have been recovered by such approaches from the phylum
Actinobacteria.
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Actinomycetes (Phylum: Actinobacteria) are well-known for their
ability to produce awealth of natural products with structural complex-
ity and with diverse biological activities (Abdelmohsen et al., 2014a,b;Julius-von-Sachs-Institute for
achs-Platz 3, 97082 Würzburg,
.R. Abdelmohsen).
. This is an open access article underAdegboye and Babalola, 2012; Hopwood, 2007; Li and Vederas, 2009;
Nett et al., 2009). However, a plethora of secondary metabolites
encoded in the actinomycete genomes remain undiscovered presum-
ably because these genes are not transcribed under conventional labo-
ratory conditions (Bentley et al., 2002; Hertweck, 2009; Ochi and
Hosaka, 2013; Pettit, 2011; Seyedsayamdost, 2014; Van Lanen and
Shen, 2006). Mathematical models predict thousands of unexplored an-
timicrobials from actinomycete genomes (Caboche, 2014; Cimermancic
et al., 2014; Watve et al., 2001). Accordingly, signiﬁcant research effortthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Hypothetical mechanisms of elicitation of secondary metabolism in bacterial cells,
the data have been derived from the already published literature: (1) Binding of elicitor
to a speciﬁc receptor or its internalization; (2) changes in the levels of intracellular mole-
cules as a response to the elicitors; (3) Activation of either the metabolite activator or the
metabolite gene cluster itself (via unknownmechanisms). CW, cell wall; CM, cytoplasmic
membrane and P, promoter.
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aim to identify new natural products and molecular scaffolds. Since
the discovery of the β-lactam antibiotic penicillin by Alexander Fleming
in 1928 (Fleming, 1929), co-cultivation ormixed fermentation has been
recognized as a remarkably successful approach for the discovery of bi-
ologically active natural products. Several recent studies have revealed
strategies to activate cryptic genes, which include chemical, biological,
and molecular elicitation (Dashti et al., 2014; Gross, 2009; Hertweck,
2009; Luo et al., 2013; Schroeckh et al., 2009; Zhu et al., 2014). Tradi-
tional approaches such as co-cultivation and changes in fermentation
conditions (media composition, pH, and temperature) are long known
to induce signiﬁcant changes in the microbial metabolome (Marmann
et al., 2014). Manipulation of the fermentation conditions is known as
“one strainmany compounds” (OSMAC) approach and represents an ef-
fective avenue for activating silent or poorly expressed metabolic path-
ways (Abdelmohsen et al., 2014a,b; Bode et al., 2002; Paranagama et al.,
2007; Wei et al., 2010). Co-cultivation has been used in the production
of foods, food additives, enzymes, bulk and ﬁne chemicals, bioremedia-
tion, and degradation of lignocelluloses. However, its application for the
production of antimicrobial compounds is still in its infancy (Bader
et al., 2010). Challenging the bacterial cells with external signals, so-
called “elicitors”, is a recognized strategy to generate novel, biologically
activemetabolites (Chiang et al., 2011;Müller andWink, 2014). Sensing
of the input signals by the producer strains results in a discrete response
that might lead to an altered metabolite proﬁle. The challenge with
small molecule chemical elicitors can enable the identiﬁcation of differ-
ent responses in microorganisms such as the increased production of
stress-response-related compounds (Romero et al., 2007), bioﬁlm for-
mation induction, and modulation of virulence expression (Bajaj et al.,
2014; Even et al., 2009; Nouaille et al., 2009). Elicitation may, in certain
rare cases, result in unaltered metabolite proﬁles or even repression of
the sought-after metabolites (Marmann et al., 2014). There are several
recent reviews on activating silent gene clusters in fungi (Brakhage,
2013; Brakhage and Schroeckh, 2011; Chiang et al., 2009), as well as
in myxobacteria (Krug et al., 2008; Wenzel and Müller, 2009), but re-
markably little is known about the activation of gene clusters in actino-
mycetes by elicitation approaches. Given that the large number of
available actinobacterial genome sequences have shown the hidden
natural product biosynthetic capacity of the phylum Actinobacteria
(Bentley et al., 2002; Doroghazi et al., 2014; Jensen et al., 2014;
Zazopoulos et al., 2003), our review will focus on elicitation of second-
ary metabolism in actinomycetes.
The chemical and molecular complexity of the elicitation process
renders the precise mechanism of elicitation poorly understood. To
date, the mechanism of the action of elicitors is best known in plants
and fungal cells (Nützmann et al., 2011; Radman et al., 2003), but less
well known than bacterial cells. The current knowledge on the postulat-
edmechanistic underpinnings of elicitation in bacteria is summarized in
Fig. 1. The elicitors are likely initially sensed by the bacterial cells as
chemical signals (Kawai et al., 2007; Murphy et al., 2011). The binding
of an elicitor to a receptor or its internalizationmay then lead to changes
in the levels of intracellular molecules such as Ca2+ ions (Murphy et al.,
2011), alarmones (Kawai et al., 2007), or reactive oxygen species (ROS)
(Radman et al., 2006). These concentration changes serve as internal
signals to direct the regulation of secondary metabolites via yet un-
known mechanisms. The elicitor can either directly inﬂuence the tran-
scription of the secondary metabolite gene cluster or induce a
transcriptional activator of the target gene cluster (Kawai et al., 2007;
Nair et al., 2009; Rigali et al., 2008; Tanaka et al., 2010).
2. Biological elicitation
2.1. Elicitation by microbial co-cultivation
Actinomycetes exist as cohorts alongwith other microbes in various
habitats. The encounter of microorganisms in their environment mayturn on cryptic gene clusters, thereby triggering the production of
new metabolites in the resident bacteria. This interaction could induce
silent pathways that might result in the synthesis of novel secondary
metabolites, and ultimately lead to chemical defense of the producing
microorganism. Co-cultivation-based elicitation can therefore lead to
the production of compounds that are not produced in monoculture,
which may help to unmask cryptic and poorly expressed metabolites.
Even though the precisemechanisms of the interaction are rarely un-
derstood (Marmann et al., 2014), various scenarios are conceivable. For
example, physical cell–cell interactions (Fig. 2A), production of small
molecules (auto-regulator/quorum sensing molecules, siderophores,
etc.), (Fig. 2B), production of enzymes that activate the metabolite pre-
cursor produced by the producer strain, yielding the active metabolite
(Fig. 2C), or horizontal gene transfer (Fig. 2D) may affect metabolite ac-
tivation or repression. The latter phenomenon happens on evolutionary
time scales and any changes are permanently ﬁxed on the recipient ge-
nome. Apart from these mechanisms, the inducer strain could also in-
duce epigenetic (e.g. histone acetylation) modiﬁcations in the
producer strain. In the above models, the interaction of the inducer
strain with the producer strain ultimately inﬂuences the secondary me-
tabolite production in the producer strain. However, the inducer and the
producer strains are not easily identiﬁed unless speciﬁc experiments, for
example, cross-feeding assays are performed. Co-cultivation strategy
thus partly simulates a real time ecological scenario wherein microbes
interact in a three dimensional space. Table 1 represents a comprehen-
sive list of elicitation experiments with live cells (co-cultivation) and
cell lysates involving actinomycetes along with the secondary
800 U.R. Abdelmohsen et al. / Biotechnology Advances 33 (2015) 798–811metabolites reported. Co-cultivation studies could be classiﬁed further
based on the sets of strains being co-cultured as (a) co-cultivation of ac-
tinomycetes with other actinomycetes; (b) co-cultivation of actinomy-
cetes with other bacteria, and (c) co-cultivation of actinomycetes with
fungi. Each of the above three categories is further elaborated in the fol-
lowing section.
2.1.1. Co-cultivation of actinomycetes with actinomycetes
Co-cultivation of two marine sponge-associated actinomycetes,
namely Actinokineospora sp. EG49 and Nocardiopsis sp. RV163, resulted
in the production of three metabolites, which were not produced when
the strains were grown independently. These metabolites were identi-
ﬁed as N-(2-hydroxyphenyl)-acetamide (1), 1,6-dihydroxyphenazine
(2), and 5a,6,11a,12-tetrahydro-5a,11a-dimethyl[1,4]benzoxazino[3,2-
b][1,4]benzoxazine (3). Of the three compounds, phenazine 2 showed
appreciable biological activity against Bacillus sp. p25 and Trypanosoma
brucei, as well as against Actinokineospora sp. EG49 itself. These ﬁndings
suggest that the newly synthesized molecules were produced by the
strains in mixed culture (Dashti et al., 2014).
Alteration in thenatural product biosynthesis occurred indifferent soil
Streptomyces strains upon co-cultivationwith themycolic acid containing
Tsukamurella pulmonis TP-B0596, Rhodococcus erythropolis, and Coryne-
bacterium glutamicum. Production of red pigments corresponding to the
benzoisochromanequinone polyketide actinorhodin (4) and the
tripyrrole undecylprodigiosin (5) by Streptomyces lividans TK-23 was
used as an indicator to target the inducer strain. Only T. pulmonis TP-
B0596 out of 400 tested inducer strainswas able to stimulate the produc-
tion of the red pigments by S. lividans TK-23. A dialysis experiment con-
ﬁrmed that this effect was a consequence of physical cell–cell
interactions. Members of the genus Corynebacterium, as well as strains
closely related to T. pulmonis (Tsukamurella pseudospumae, Tsukamurella
spumae, Tsukamurella strandjordii) showed a similar effect in stimulating
the production of the red pigments by S. lividans TK-23. The role of
mycolic acid was conﬁrmed by the use of a mycolic acid biosynthesis de-
letion mutant (pks 13) of C. glutamicum that was unable to activate red
pigment production in S. lividans. Furthermore, upon treatment of the
co-culture with isoniazid, a mycolic acid synthase inhibitor, the red pig-
ment production by S. lividans TK-23 was not activated, thus highlighting
the efﬁcacy of mycolic acid in activating the red pigment production, al-
though mycolic acid per se had no effect. In addition, the combined cul-
ture of a Steptomyces endus S-522 with T. pulmonis resulted in the
production of a novel antibiotic alchivemycin A (6) with activity against
Micrococcus luteus. The compound was produced only in co-culture.
Hence, co-cultivationwithmycolic acid containing bacteria is one elegantFig. 2. Putative consequences of co-cultivation: (A) physical cell to cell interactions, (B) sma
(D) horizontal gene transfer.way to activate silent gene clusters (Moody, 2014; Ochi and Hosaka,
2013; Onaka et al., 2011).Co-culture of a multi-antibiotic resistant mutant strain of Rhodococcus
fascianswith Streptomyces padanus led to the emergence of a new strain
Rhodococcus307CO thatwas found to encompass a large segment of geno-
mic DNA from S. padanus (Kurosawa et al., 2008). Fermentation of
Rhodococcus 307CO in the production medium led to the synthesis of op-
tically active, hydrophilic isomers of a new class of aminoglycosides,
rhodostreptomycins A (7) and B (8). The compounds were not produced
by themutant strain of R. fascians,which implies the essential role of hor-
izontal gene transfer in the synthesis of the rhodostreptomycins. Anti-
microbial assays against a panel of microbes (S. padanus, Bacillus subtilis,
Staphylococcus aureus, Escherichia coli,Helicobacter pylori, and Saccharomy-
ces cerevisiae) demonstrated that β-isomer 7was more active than the α
form 8 (Kurosawa et al., 2008). Even though the exact mechanism of
horizontal gene transfer from S. padanus to R. fascians remains unknown,
antibiotic synthesis followed byways of horizontal gene transfer provides
a novel avenue for elicitation of novel metabolites in actinomycetes.ll molecule-mediated interactions, (C) catalytic activation of metabolite precursor and
Table 1
Comprehensive list of secondary metabolites reported upon elicitation with live cells (co-cultivation) and cell lysates.
Interaction partners Induced secondary metabolites Activity Reference
A — Elicitation with live cells
Actinomycetes–Actinomycetes N-(2-hydroxyphenyl)-acetamide (1) – Dashti et al. (2014)
Actinokineospora sp. EG49 (U) 1,6-dihydroxyphenazine (2) A, AT
Nocardiopsis sp. RV163 (U) 5a,6,11a,12-tetrahydro-5a,11a
dimethyl[1,4]benzoxazino[3,2b][1,4]benzoxazine (3)
–
Steptomyces endus S-522 (P) Alchivemycin A (6) A Moody (2014), Ochi and Hosaka (2013)
and Onaka et al. (2011)
Tsukamurella pulmonis TP-B0596 (I)
Rhodococcus 307CO (P) Rhodostreptomycin A (7) A Kurosawa et al. (2008)
Co-culture of Rhodococcus fascians, and
Streptomyces padanus
Rhodostreptomycin B (8) A
Streptomyces tanashiensis IAM0016 (P) Unknown antibiotics against B. subtilis A Yamanaka et al. (2005)
Streptomyces griseus st-21-2 (I)
Streptomyces coelicolorM145 (P) γ-Actinorhodin (11), Prodiginine (12) A Moody (2014) and Traxler et al. (2013)
Amycolatopsis sp. AA4 (I) Acyl-desferrioxamines (14–17) IS
Streptomyces sp. E14 (I) Acyl-desferrioxamines (14–17) IS
Streptomyces sp. SPB74 (I) Actinorhodin (11), Prodiginine (12) IS
Streptomyces virdiochromogenes (I) Acyl-desferrioxamines (14–17) IS
Streptomyces albus (I) Actinorhodin (11), Prodiginine (12), Desferrioxamine E (9) IS
Actinorhodin (11), Prodiginine (12), Desferrioxamine E (9),
Desferrioxamine B (10)
Actinomycetes–other bacteria Undecylprodigiosin (5) A Luti and Mavituna (2011)⁎
Streptomyces coelicolor A3 (2) (P)
Bacillus subtilis (I)
Streptomyces coelicolor (P) Actinorhodin (4) A Perez et al. (2011)
Myxococcus xanthus (I)
Streptomyces griseorubiginosus 43708 (P) Biphenomycin A (18) A Ezaki et al. (1992) and Ezaki et al. (1993)
Pseudomonas maltophilia 1928 (I) Biphenomycin C (19) A
S. coelicolorM145 (P) Undecylprodigiosin (5) A Schäberle et al. (2014)
Corallococcus coralloides B035 (I)
Streptomyces tejamariensis SS-939 (ATCC 31603) (P) Istamycin (20) A Slattery et al. (2001)
12 unidentiﬁed bacteria (I)
Actinomycetes–Fungi Sulfated formyl xanthocillin analogue Fumiformamide (21) CT(−) Zuck et al. (2011)
Aspergillus fumigatus (P)
Streptomyces peucetius ATCC 29050 (I) N,N′-((1Z,3Z)-1,4-bis(4-methoxyphenyl)buta-1,
3-diene-2,3-diyl)diformamide (22)
CT
N-formyl derivatives (23, 24) CT(−), CT
Xanthocillin analogue BU-4704 (25) CT(−)
Emericella sp. (strain CNL-878) (P) Emericellamides A (26) A, CT Oh et al. (2007)
Salinispora arenicola (strain CNH-665) (I) Emericellamides B (27) A, CT
Aspergillus nidulans (P Orsellinic acid (28) NT Chiang et al. (2011)
and Schroeckh et al. (2009)
Streptomyces rapamycinicus (I) Lechanoric acid (29) NT
Cathepsin-K inhibitor F-9775A (30) NT
Cathepsin-K inhibitor F-9775B (31) NT
Aspergillus fumigatus (P) Fumicycline A (32) A König et al. (2013) and Marmann et al. (2014)
Streptomyces rapamycinicus (I) Fumicycline B (33) A
Aspergillus fumigatusMBC-F1-10 (P) Ergosterol (34) NT Marmann et al. (2014) and Rateb et al. (2013)
Steptomyces bullii (I) Brevianamide F (35) CT
Spirotryprostatin A (36) AT, L, CT
6-methoxyspirotryprostatin B (37) L, CT
Fumitremorgin C (38) AT, L, CT
12,13-Dihydroxyfumitremorgin C (39) AT, L, CT
Fumitremorgin B (40) AT, L, CT
Verruculogen (41) AT, L, CT
11-O-methylpseurotin A (42) CT
11-O-methylpseurotin A2 (43) L, CT
Fusarium tricinctum (P) Enniatin B (47) – Ola et al. (2013)
Streptomyces lividans (I) Enniatin B1 (48) A
Enniatin A1(49) A
Fusaristatin A (50) –
4 unknown metabolites NT
B—Elicitation with cell lysates
(continued on next page)
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Table 1 (continued)
Interaction partners Induced secondary metabolites Activity Reference
Streptomyces coelicolor A3(2) (P) Undecylprodigiosin (5) A Luti and Mavituna (2011) and Anon. (2011)⁎
Heat-killed/dead cells of Bacillus subtilis (I)
Streptomyces coelicolor A3(2) (P) Undecylprodigiosin (5) A Luti and Mavituna (2011)⁎
Heat-killed/dead cells of Staphylococcus aureus (I)
P = producer strain; I = inducer strain; A = antibiotic; AT = antitrypanosomal; L = leishmanicidal; CT = cytotoxic; CT (−) = no cytotoxicity; NT = not tested; – = inactive; U =
producer/inducer strain unknown; IS = iron siderophore induction. *Elicitation efﬁciency using live/dead cells as elicitors is approximately similar.
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identiﬁed as the siderophore desferrioxamine E (9), from Streptomy-
ces griseus st-21-2 stimulated growth, altered morphological devel-
opment, and induced antibiotic production in Streptomyces
tanashiensis IAM0016 (Yamanaka et al., 2005). Treatment of
S. griseus, Streptomyces coelicolor A3 (2) and ﬁve soil actinomycetes
with compound 9 showed a similar pattern in that aerial growth,
morphological changes, pigment, and antibiotic production were
stimulated, while treatment with the commercially available
desferrioxamine E analogue desferrioxamine B (10) showed a
much weaker stimulation. Disruption of the biosynthesis genes of 9
in the des operon of S. coelicolor A3(2) and subsequent restoration
of the des mutant by exogenous supply of 9 suggested the effect of
siderophores in activation of S. coelicolor A3 (2) growth, develop-
ment and secondary metabolism. None of the other known
siderophores displayed a stimulatory effect on S. tanashiensis
IAM0016, indicating siderophore speciﬁcity for this strain. Therefore,
siderophores produced by microbial neighbors can induce growth,
development and secondary metabolism in siderophore defective
strains.
The chemical response of S. coelicolorM145 to the interactions in
a co-culture with 5 initiator strains (Amycolatopsis sp. AA4 (A), Strep-
tomyces sp. E14 (E), Streptomyces sp. SPB74 (S), Streptomyces
virdiochromogenes (V) and Streptomyces albus (J)) was deciphered
employing Nano-DESI MS (nanospray desorption electrospray ioni-
zation mass spectrometry) and MALDI-TOF (matrix-assisted laser
desorption ionization-time-of-ﬂight) imaging mass spectrometry.
S. coelicolor M145 and the initiator strains were spotted 5 mm
apart on an agar plate. Spectral networking revealed an array of
629 compounds as a consequence of these interactions. Antibiotics
such as γ-actinorhodin (11) and prodiginine (12) were stimulated
in S. coelicolor M145 upon interaction with the A, S, V, J strains but
not strain E. Genome sequencing of these initiator strains revealed
the absence of antibiotic 11 and 12 biosynthetic genes indicating
that these are produced by S. coelicolor M145 only in the co-
culture. The NRPS siderophore peptide coelichelin (13) was found
only occasionally except in the interaction between S. coelicolor
M145 and the other ﬁve strains with V strain. Furthermore, the
gene clusters or genes for coelichelin biosynthesis were identiﬁed
in V, which raises the possibility of this molecule being produced
by either of the strains upon interaction. Production of the
siderophore desferrioxamines of varying acyl chain lengths (14–
17) were observed in S. coelicolor (in the Nano-DESI spectral
networks) upon interaction with siderophore-producing neighbor-
ing strains that facilitate a competition of iron between the species.
Acyl-desferrioxamines (Acyl-DFO) were observed in the interactions
with strains A, E, and S, and not with V and J. In the interactions with
the strains V and J, the cyclic siderophore desferrioxamine E (9) was
observed, while the linear analogue desferrioxamine B (10) was de-
tected in the interaction with J. Furthermore, A and E were found to
have no operons for desferrioxamine synthesis in their genomes
like the other initiator strains, indicating that the production of
desferrioxamines in these interactions is solely due to S. coelicolor,
which was not the case with the other initiator strains (Moody,2014; Traxler et al., 2013). Hence, emerging new analytical
techniques such as Nano-DESI MS and MALDI-TOF to study the
chemical communication in an actinomycete co-culture constitute
a modern strategy in understanding the complex patterns in
metabolite shifts and focus on novel metabolites in complex
interaction schemes.2.1.2. Co-cultivation of actinomycetes with other bacteria
Predator microbes that kill and feed on other live bacterial cells
by absorbing their nutrients can also activate the expression of an-
tibiotics in producer organisms. Myxococcus xanthus, a predator of
S. coelicolor, was shown to induce the blue polyketide antibiotic
actinorhodin (4) in the producer organism, as well as trigger aerial
mycelium production on solid media (Perez et al., 2011). Further-
more, actinorhodin-producing cells were not surrounded by
M. xanthus indicating that S. coelicolor could use compound 4 as a
repellant signal against M. xanthus. Production of compound 4
was also upregulated in the presence of other strains such as Bacil-
lus megaterium, B. subtilis, Bacillus thuringensis, and Serratia sp.,
however, the strongest upregulation was observed with
M. xanthus. Liquid co-cultures of S. coelicolor with M. xanthus
DK1622 and S. coelicolor with M. xanthus DZF1 resulted in a 20-
fold elevation in the production of 4 when compared to
S. coelicolormonoculture. Thus, the use of predator strains is anoth-
er way to unravel the expression of metabolites that remain silent
or poorly expressed in axenic cultures.
Co-culture of the producer strain Streptomyces griseorubiginosus
43708 and Pseudomonas maltophilia 1928 resulted in a 60-fold increase
of the cyclic peptide antibiotic biphenomycin A (18) when compared to
the pure culture that produced low levels of 18. Treatment of
S. griseorubiginosus 43708 with the cell free extract of P. maltophilia
1928 also led to the production of peptide 18. This implied that the in-
crease in production of 18was not a consequence of mere cell–cell inter-
action but rather due to the presence of speciﬁc enzymes in themycelia of
strain 1928. These enzymes converted the precursor of biphenomycin A
to its active form 18 in the co-culture and these enzymes were thought
to be absent in the producer strain owing to production of low levels of
the compound (Ezaki et al., 1992). Later on, the peptide precursor of 18,
biphenomycin C (19) (composed of 18 and arginylserine residue), was
isolated and structurally identiﬁed from the mixed culture. Experiments
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converts the precursor 19 to 18 and arginylserine. Precursor 19 also pos-
sessed anti-bacterial activity against Gram-positive pathogens but the ac-
tivity was lower when compared to that of 18 (Ezaki et al., 1993). Thus,
the presence of certain enzymes in the inducer strains could convert pre-
cursors produced by producer strains to the active metabolite, leading to
accumulation of novelmetabolites in the co-culture and not in themono-
culture that are lacking these enzymes.
Co-cultivation of the soil bacterium S. coelicolor M145 with the
corallopyronin A-producing myxobacterial strain Corallococcus
coralloides B035 resulted in an increased production of the bioactive
metabolite undecylprodigiosin (5) by S. coelicolor M145 when com-
pared to the axenic culture (Schäberle et al., 2014). Treatment of
S. coelicolor M145 with live or dead cells, or watery extract of
C. coralloides B035 caused a 1.5-fold increase in the extracellular con-
centration and a 60-fold increase in the intracellular concentration of
5. Elicitation of undecylprodigiosin in this co-cultivation approach was
due to a hydrophilic and thermo-stable molecule from C. coralloides
B035 that served as the signal for undecylprodigiosin production. This
highlights the use of myxobacterial competitors as biotic elicitors in en-
hancing the production of bioactive metabolites. Changes that occurred
during the co-cultivation can inﬂuence the expression of metabolites.
Co-cultivation of the soil microorganisms S. coelicolor M145 and
Pseudomonas ﬂuorescens BBc6R8 revealed that the acidiﬁcation of the
R2medium by P. ﬂuorescens BBc6R8 inhibited the production of the dif-
fusible, blue pigmented antibiotic γ-actinorhodin (11) without altering
the intracellular red pigmented actinorhodin (4) by S. coelicolorM145.
This inhibition in the production of the lactone form of actinorhodin
was attributed to a reduction in the pH of the medium due to synthesis
of gluconic acid from glucose. A similar effect was observed with
S. coelicolor M145 in co-culture with gluconic acid-producing bacteria
like ﬂuorescent Pseudomonas strains, the opportunistic pathogen Pseu-
domonas aeruginosa PAO1 and the β-proteobacteria Collimonas PMB3
(Galet et al., 2014). Thus, pH changes duringmixed fermentation can af-
fect the metabolite expression, and in consequence, modulate the ex-
pression of unknown metabolites.
The inﬂuence of competition between 53 marine bacteria with the
istamycin (20) producing marine bacterium Streptomyces tejamariensis
SS-939 was investigated to study the role of the antibiotic istamycin in
competitive interactions between microbes under natural conditions.
Twelve of the 53 strains induced the production of istamycin (20) in
co-culture with S. tejamariensis SS-939. The co-cultures doubled the
production of 20 when compared to the axenic mono-culture of
S. tejamariensis (Slattery et al., 2001).
2.1.3. Co-cultivation of actinomycetes with fungi
Mixed fermentation of Streptomyces peucetius ATCC 29050 and
Aspergillus fumigatus yielded two newmetabolites, namely the sulfated
formyl xanthocillin analogue fumiformamide (21) and N,N′-((1Z,3Z)-
1,4-bis(4-methoxyphenyl)buta-1,3-diene-2,3-diyl)diformamide (22)along with two previously known N-formyl derivatives 23, and 24, as
well as the new xanthocillin analogue BU-4704 (25) (Isaka et al.,
2007). Compound 22 exhibited toxic effects on a broad spectrum of
cell lines and compound 24 displayed moderate cytotoxicity, while no
cytotoxic effects were observed for the other compounds (Zuck et al.,
2011).
Anti-MRSA (Multi-drug Resistant S. aureus) cyclic depsipeptides,
emericellamides A (26) and B (27) were obtained from the marine
derived fungus Emericella sp. strain CNL-878 in co-culture with
the marine actinomycete Salinispora arenicola strain CNH-665.
Axenic culture of the Emericella sp. produced undetectable amounts
of metabolites 26 and 27. The co-culture of Emericella sp. with
S. arenicola elevated the production of metabolites 26 and 27 by
100-fold and made the structural elucidations of these compounds
feasible. Emericellamides A and B had moderate activities against
MRSA, as well as weak cytotoxicity against HCT-116 human colon
carcinoma cell lines (Oh et al., 2007).
Speciﬁc polyketides were produced in Aspergillus nidulans upon
co-culture with soil dwelling actinomycetes. A. nidulans secondary
metabolism array (ASMA), microarray, quantitative RT-PCR,
northern blot and full genome array results indicated that the bac-
teria, upon physical contact, activate certain fungal genes. Only
Streptomyces hygroscopicus (ATCC 29253) among 58 bacterial soil
isolates elicited the expression of two secondary metabolite gene
clusters in A. nidulans. Transcriptome analysis revealed differential
expression of about 395 fungal genes in the co-culture, of which
248 and 147 genes were signiﬁcantly up- and down-regulated,
respectively. HPLC analysis of the co-culture inferred the produc-
tion of polyketides orsellinic acid (28), lechanoric acid (29), and
cathepsin-K inhibitors F-9775A (30) and F-9775B (31). Further-
more, dialysis and the electron microscopy experiments revealed
that the physical contact of the S. hygroscopicus with A. nidulans
elicited metabolite production in the fungal cells and not the low
molecular weight signaling molecules from the bacterial cells
(Chiang et al., 2011; Schroeckh et al., 2009). This indicates that
physical interaction of microorganisms is required to elicit expres-
sion of silent gene clusters in speciﬁc interaction sets. Differential
gene expression in A. nidulans upon physical interaction with the
S. hygroscopicus (Streptomyces rapamycinicus) is a consequence of
fungal histone modiﬁcation via the Histone Acetyl Transferase
(HAT) complex Saga/Ada containing the proteins GcnE and AdaB
that induces the orsellinic acid gene cluster (König et al., 2013;
Nützmann et al., 2011).
A similar co-culture study of S. rapamycinicus and A. fumigatus led to
the activation of novel C-prenylated polyketides fumicyclines A (32)
and B (33) in A. fumigatus. Full genome microarray analysis revealed
the upregulation of a large number of fungal genes. Agar diffusion
assay against S. rapamycinicus showed the ability of 32 and 33 to act
804 U.R. Abdelmohsen et al. / Biotechnology Advances 33 (2015) 798–811as fungal defense molecules, since both showed signiﬁcant anti-
bacterial activity against S. rapamycinicus. Dialysis experiments and
experiments involving addition of bacterial cell free supernatants
proved that direct physical contact between S. rapamycinicus and
A. fumigatus was essential for metabolite induction (König et al.,
2013). Hence, physical interaction between microbial sets regulates
gene expression, facilitating the production of bioactive metabolites as
a defense strategy aimed at survival in a competitive environment.
Quorum sensing molecules could also induce the secondary me-
tabolite production in actinomycetes. Metabolites possessing
antiprotozoal activities were induced in a co-culture of A. fumigatus
MBC-F1-10 with the soil isolate Streptomyces bullii strain C2. Com-
pounds of fungal origin including triterpene ergosterol (34),
diketopiperazine alkaloids brevianamide F (35), spirotryprostatin A
(36), 6-methoxyspirotryprostatin B (37), fumitremorgin C (38) and
its 12,13-dihydroxy derivative (39), fumitremorgin B (40),
verruculogen (41), 11-O-methylpseurotin A (42) and the epimer
11-O-Methylpseurotin A2 (43) were reported in the co-culture and
were not observed in the axenic cultures. Neither the medium devoid
of bacteria nor the methanolic extract of bacterial cells or the heat
inactivated bacterial cell fraction elicited the metabolite response in the
co-culture. Treatment of A. fumigatusMBC-F1-10 with the bacterial quo-
rum sensing molecule N-butyryl-DL-homoserine lactone resulted in the
production of di- and tri-sulﬁdes emestrins A and B (44 and 45) in the
fungal culture. Fumitremorgin B (40) and verruculogen (41) exhibited
potency against T. brucei and Leishmania donovani but also pronounced
cytotoxicity against human lung ﬁbroblasts MRC5 cells (Rateb et al.,
2013). Thus, interactions in a co-culture, as well as the differential re-
sponse to the bacterial quorum sensing molecules could trigger newme-
tabolite production.Co-culture of the plant endophytic fungus Fusarium tricinctum
with B. subtilis 168 trpC2 on the solid rice medium led to a 78-fold
increase in lateropyrone (46), enniatin-type cyclic depsipeptides
enniatins B (47), B1 (48), and A1(49), as well as the lipopeptide
fusaristatin A (50), over the axenic fungal culture. The same co-
culture experiment yielded three new natural products, namely
macrocarpon C (51), 2-(carboxymethylamino) benzoic acid (52), and
(−)-citreoisocoumarinol (53) along with (−)-citreoisocoumarin (54).
The four compounds were detected only in the co-culture and not in ei-
ther mono-culture. Co-culture of F. tricinctum with S. lividans showed a
similar increase in the accumulation of compounds 47–50. Additionally,
four new unidentiﬁed metabolites were reported that were differ-
ent from the four metabolites produced in the co-culture of
F. tricinctum with B. subtilis 168 trpC2. These results indicate the
speciﬁc response of the fungus to different bacterial cells. Only
the cyclic depsipeptides enniatin A1(49) and enniatin B1 (48)
had anti-bacterial activities against B. subtilis 168 trpC2 with an
MIC of 8 and 16 μg/ml, respectively, as well as against pathogens
S. aureus, Streptococcus pneumoniae, and Enterococcus faecalis,
while enniatin B (47) was inactive. Lateropyrone (46) also showed
signiﬁcant activity against B. subtilis 168 trpC2, S. aureus,
S. pneumoniae, and E. faecalis (Ola et al., 2013).2.2. Elicitation with microbial lysates
The yield of undecylprodigiosin (5), an antibiotic with immunosup-
pressive properties and apoptotic effects against breast cancer cells
(Anon., 2011; Ho et al., 2007; Luti and Mavituna, 2011; Williamson
et al., 2006) by S. coelicolor A3 (2) was increased upon treatment with
live and heat killed cells of B. subtilis, while pure cultures of
S. coelicolor A3 (2) produced only extremely low concentrations of 5.
Undecylprodigiosin was produced on solid medium at the interface of
the B. subtilis (inducer strain) and the S. coelicolor A3 (2) (producer
strain), but not by the producer strain alone. This indicated that
B. subtilis induced the production of 5 in S. coelicolor A3 (2). Moreover,
the cell wall components (N-acetyl glucosamine and the peptidoglycan)
did not result in induction of 5, while the entire cell lysate induced its
production (Luti and Mavituna, 2011). Because a speciﬁc elicitor mole-
cule could not be identiﬁed, the exact mechanism remains unknown.
In another study, production of compound5was elicited following addi-
tion of the heat killed cells of B. subtilis and S. aureus at the time of inoc-
ulation alongwith the S. coelicolorA3 (2) (producer strain). This resulted
in a 3- and 5-fold increase in the production of 5 in the B. subtilis and
S. aureus treated cultures, respectively. The higher yield with heat-
killed S. aureus over B. subtilis may relate to the fact that the human-
skin associated S. aureus is more foreign to S. coelicolor than B. subtilis,
the latter of, which are natural soil dwellers (Luti and Mavituna,
2011). Hence, simulating the presence of a competing environment
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force for cryptic bioactive metabolite gene expression in actinomycetes.
2.3. Elicitation with microbial cell components
Cell wall constituents, microbial hormones or signaling molecules,
carbohydrates or biopolymers derived from cells could be employed
as elicitors in provoking secondary metabolism. Table 2 shows a com-
prehensive list of cell-derived elicitors that stimulate secondary metab-
olism in actinomycetes.
Nutritional status of the microbial milieu might also inﬂuence the
production of antibiotics. The cell wall component and the chitinmono-
mer N-acetylglucosamine (GlcNAc) elicited the production of
actinorhodin (4) and undecylprodigiosin (5) by S. coelicolor under
poor nutrient conditions, whereas GlcNAc impeded the antibiotic pro-
duction under rich nutrient conditions. This nutrient-based elicitation
of GlcNAc was found to be associated with the DNA binding protein
DasR. DasR responsive elements (dre) (the DNA binding sites of DasR)
were found upstream to the activators of 4 and 5 (redZ). Electrophoretic
mobility assays and RT-PCR analysis demonstrated that the binding of
DasR to the dre regions upstream to actII-ORF4 and redZ, down-regulat-
ed the antibiotic production. Challenging S. coelicolorwithGlcNAc under
famine conditions caused a derepression of antibiotic production by
DasR mutant due to the allosteric binding of GlcN-6P (glucosamine-6-
phosphate) to DasR. Enhanced transcript levels of ‘kasO’, an activator
of a cryptic gene cluster, was observed in the case of the DasR mutant
S. coelicolor BAP29, highlighting the role of DasR in silencing gene clus-
ters by repression of the corresponding activator of the cluster. Accord-
ingly, interference with DasR activity could induce antibiotic
production. GlcNAc induced antibiotic production in Streptomyces
clavuligerus, Streptomyces collinus, S. griseus, S. hygroscopicus and
Streptomyces venezuelae, when grown on poor nutrient medium, indi-
cating their widespread antibiotic elicitation effect within the Strepto-
myces genus (Ochi and Hosaka, 2013; Rigali et al., 2008; Zhu et al.,
2014). Thus, treatment of actinomyceteswith GlcNAc under speciﬁc nu-
trient conditions is one novel way to awaken cryptic secondary metab-
olism gene operons.
Biosynthesis of the anti-fungal polyethylene antibiotic natamycin or
pimaricin (55) by Streptomyces natalensis HW-2 was enhanced uponTable 2
Comprehensive list of secondary metabolites reported upon elicitation with cell-derived comp
Elicitor Strain Secondary
metabolites
induced
N-acetylglucosamine Streptomyces coelicolor Actinorhodin (4)
[Under poor nutrient conditions] Undecylprodigiosi
Unidentiﬁed fungal elicitor from
Penicillium chrysogenum AS 3.5163
S. natalensis HW-2 Pimaricin (55)
N-butyryl-DL-homoserine lactone (HSL) Aspergillus fumigatus
MBC-F1-10 (P)
Emestrin A (44)
Emestrin B (45)
PI-factor S. natalensis Pimaricin (55)
Glycerol
1,2 Propanediol S. natalensis npi287 Pimaricin (55)
1,3 Propanediol ethylene glycol
Oligosaccharides & polysaccharides S. rimosus Unidentiﬁed secon
metabolitesPenicillium chrysogenumelicitation with a structurally unidentiﬁed fungal elicitor from Penicillium
chrysogenum AS 3.5163. Both, the heat killed biomass and the fermenta-
tion broth of P. chrysogenum AS 3.5163 enhanced the production of 55.
This fungal elicitor from P. chrysogenum AS 3.5163 enhanced the yield of
natamycin asmuch as 200%when compared to the untreated control. Pri-
mary quantitative analysis revealed that the elicitor from the fermenta-
tion broth of P. chrysogenum AS 3.5163 was found to be a low molecular
weight molecule with polarity comparable to that of butanol (Wang
et al., 2013).
Cross-feeding experiments and pairing analysis of strains of
Streptomyces sp. was done in three sets with Streptomyces strains
from a culture collection and freshly isolated Streptomyces strains
from two different soil environments. Higher frequency of cross-
activation of antibiotic production and sporulation reported in
pairwise strains of the fresh isolate reﬂected the higher incidence
of such interactions in their natural habitats. The higher frequency
of antibiotic production and sporulation in the pairs from culture col-
lection was attributed to the genetic diversity of the strains in the
collection. Externally added Streptomyces auto-regulators like A-
factor or the virginae butanolide-C or γ-nonalactone did not activate
the antibiotic production. This demonstrated that different factors
were produced upon interactions of strains. The stimulation of anti-
biotics in the receiver strain by the ethyl acetate extracts of stimula-
tor strains explains that the unknown diffusible factors might lead to
antibiotic synthesis (Ueda et al., 2000).
Microbial hormones such as γ-butyrolactones in Streptomyces sp.
regulate secondary metabolism and strain morphology (Waters and
Bassler, 2005). One such example is the pimaricin (natamycin) (55)
production by S. natalensis that was found to be elicited by the hy-
drophilic molecule PI factor [2,3-diamino-2,3-bis(hydroxymethyl)-
1,4-butanediol] produced by this strain. The S. natalensis npi287 PI
factor mutant strain that cannot synthesize PI factor failed to produce
pimaricin, thus explaining the role of PI factor in eliciting the biosynthesis
of compound 55. It has been shown that A-factor from S. griseus restored
the pimaricin biosynthesis in PI factor mutant of S. natalensis, while con-
versely, PI factor did not elicit the production of streptomycin (56) in
the A-factor mutant strain of S. griseus. This indicated that the activity of
the PI factor was restricted to S. natalensis. Treatment of the wild type
S. natalensiswith pure PI factor resulted in an increase in the pimaricinonents.
Mechanism of elicitation References
Binding of glucosamine-6-phosphate
to DasR led to de-repression in
antibiotic synthesis
Ochi and Hosaka (2013),
Rigali et al. (2008) and
Zhu et al. (2014)
n (5)
Low molecular weight molecule from
broth of P. chrysogenum AS 3.5163
displayed an elicitation effect
Wang et al. (2013)
Marmann et al. (2014) and
Rateb et al. (2013)
Hydrophilic auto inducer molecule regulated
antibiotic production
Recio et al. (2004) and
Zhu et al. (2014)
Glycerol altered membrane permeability and
led to internalization of the auto inducer
PI-Factor
Recio et al. (2006) and
Wang et al. (2013)
dary Inhibition of Reactive Oxygen Species
(ROS) led to overproduction of secondary
metabolites
Radman et al. (2006)
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ol elicited pimaricin production in the PI factor defective strain npi287 of
S. natalensis. Alcohols 1,2 propanediol, 1,3 propanediol and ethylene gly-
col also had similar induction effect onpimaricin biosynthesis but their in-
duction effects were lesser when compared with the effects of glycerol.
A rapid elicitor screening platform inmicrobial andmammalian sys-
tems was developed based on the elicitor mediated inhibition of reac-
tive oxygen species (ROS) and the subsequent overproduction of
secondary metabolites (Radman et al., 2006). The effect of certain car-
bohydrate elicitors on overproduction of secondary metabolites was
then assessed in Streptomyces rimosus M4018 and P. chrysogenum P2
strain ATCC 48271. ROS generation was evaluated using 2′, 7′-
dichloroﬂuorescein diacetate (DCFH-DA) as an indicator. Mannan oligo-
saccharides showed themost potent inhibition of ROSon all the systems
assessed and overproduction of secondary metabolites as well. Thus
chemical molecules repressing the ROS production in microbes could
serve as elicitors of microbial secondary metabolites.
Antibiotics at sublethal concentrations can generate diversemetabolic
responses in bacteria (Imai et al., 2015). Identiﬁcation of elicitors that in-
duce the expression of silent gene clusters under standard conditions is
however a challenge. Recent work by Seyedsayamdost (2014) describes
the development of a high throughput platform for the identiﬁcation of
elicitors of silent gene clusters in bacteria employing screening of small
molecule libraries and genetic reporter fusions (e.g., lacZ/GFP), in order
to assess the expression of the known cryptic gene cluster of interest.
The elicitation effects of libraries composed of small molecules on twoTable 3
Comprehensive list of secondary metabolites reported upon chemical elicitation.
Elicitor Strain Secondary
metabolites
induced
Mechanism
ARC2 S. coelicolor Germicidins A–C (57–59),
Actinorhodin (4)
Inhibition o
by inhibitio
protein red
S. peucetius Unknown metabolites
Scandium (Sc3+) S. coelicolor Actinorhodin (4) Upregulatio
transcripts
alarmone p
(Sc3+) to r
S. antibioticus & S. parvulus Actinomycin D (61)
S. griseus Streptomycin (56)
Bacillus subtilis 168 Bacilysin (62)
Scandium and
Lanthanum
S. coelicolor A3 (2) Actinorhodin (4) Nine genes
products un
of action un
DMSO S. venezuelae ATCC 10712 Chloramphenicol (63) Effect at th
translation
S. glaucescens Tetracenomycin C (64)
S. azureus ATCC 14921 Thiostrepton (65)
S. lividans Prodigiosin (5)
Ethanol S. glaucescens Tetracenomycin C (64) –
Dimethyl
sulphone
S. venezuelae ATCC 10712 Chloramphenicol (63) –
Ethanol S. venezuelae ISP5230 Jadomycin B (66) Induced eit
or served a
or altered m
S. venezuela
Sodium butyrate S. coelicolor Actinorhodin (4) HDAC inhib
– = Possible mechanism of elicitation not mentioned.gene clusters (mal that is responsible for the expression of the virulence
factor malleilactone and bhc, which is responsible for the expression of
a histone deacetylase inhibitor) in Burkholderia thailandensis E264 were
studiedusing lacZ fusions to putative genes in these clusters. Nine elicitors
from a library of 640 compounds against themal cluster and ﬁve elicitors
from a library of 800 compounds against the bhc cluster were discovered.
It was deduced that the majority of these antibiotics were active at sub-
inhibitory/low concentrations. Thus with the aid of genetic manipulation
encompassing reporter fusions, chemical molecule library platforms, and
newmass spectrometric techniques it is now possible to identify elicitors
for gene clusters of interest of, which product is either known or can be
predicted by computational approaches.3. Chemical elicitation
Chemical elicitation involves compounds of non-biological origin for
elicitation process, which result in changes in the metabolomic proﬁle.
Chemical elicitors include inorganic compounds, rare earth elements,
heavy metal ions, etc. The elicitation response depends on which/how
many defense pathways are triggered and how strongly the pathways
are activated. Table 3 shows a comprehensive list of chemical elicitors
that have been shown to stimulate secondary metabolism in
actinomycetes.
Screening of Streptomycetes with a Canadian compound collection
encompassing 30,569 small molecules led to the identiﬁcation of 19
compounds, which altered secondary metabolism (Craney et al.,
2012). Four out of the nineteen compounds, called the “antibiotic re-
modeling compounds” (ARCs; ARC2, ARC3, ARC4, ARC5), induced
actinorhodin (4) production in S. coelicolor. Treatment of S. coelicolor
with the most active compound, ARC2, resulted in an elevation in the
levels of the pyranones germicidins A–C (57–59) by three-fold and a re-
tardation in the levels of prodiginines and daptomycin-like calcium de-
pendent antibiotic CDA 4a (60) by S. coelicolor. LC–MS analysis revealedof elicitation References
f fatty acid biosynthesis
n of enoyl–acyl carrier
uctase FabI
Craney et al. (2012), Ochi and Hosaka (2013),
Ochi and Okamoto (2012) and
Zhu et al. (2014)
n of antibiotic activator
and decrease in the bacterial
pGpp levels by binding of Scandium
ibosome alters antibiotic production
Kawai et al. (2007) and
Ochi and Hosaka (2013)
upregulated, several
identiﬁed. Mechanism
known
Ochi and Hosaka (2013), Ochi et al. (2014),
Tanaka et al. (2010) and Zhu et al. (2014)
e
al level
Chen et al. (2000) and Pettit (2011)
her a heat shock response,
s a metabolite precursor,
embrane permeability in
e ISP5230
Doull et al. (1994) and Pettit (2011)
itor Moore et al. (2012) and Zhu et al. (2014)
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actinomycetes strains like Streptomyces pristinaespiralis, S. peucetius, and
Kutzneria sp. 744, indicating that the ARC2 mechanism is conserved
among various actinomycetes. ARC2 showed structural synonymy
with a fatty acid synthesis inhibitor and it was shown to affect second-
arymetabolite yields. It inhibited fatty acid biosynthesis through inhibi-
tion of enoyl–acyl carrier protein reductase FabI, an enzyme that
catalyzes the rate limiting and ﬁnal step in fatty acid biosynthesis.
Fatty acid synthesis (primary metabolism) and polyketide synthesis
(secondary metabolism) share acyl-CoA precursors (malonyl-CoA &
acetyl-CoA). Thus ARC2 might act through the partial inhibition of
enoyl–acyl carrier protein reductase FabI leading to a halt in the primary
metabolism and diverting at the same time the precursor ﬂow towards
antibiotic production. ARC2 treatment also induced the expression of un-
known metabolites in S. peucetius, thus explaining the role of the elicitor
in the discovery of new metabolites (Craney et al., 2012; Ochi and
Hosaka, 2013; Zhu et al., 2014). Thus reconﬁguring the metabolism by
smallmolecules likeARC2 and triclosan that inhibit fatty acid biosynthesis
or primary metabolism is an effective approach in enhancing polyketide
synthesis and activating silent polyketide gene clusters in actinomycetes.
Elicitation effects were observed on the antibiotics actinorhodin (4),
dactinomycin (61), streptomycin (56), and bacilysin (62) production by
S. coelicolor, Streptomyces antibioticus, and Streptomyces parvulus,
S. griseus and B. subtilis 168 upon treatment with the rare earth element
(REE) scandium (Sc3+). Other REEs like Yttrium (Y), Lanthanum (La),
Cerium (Ce), and Europium (Eu) also upregulated actinorhodin produc-
tion in S. coelicolor. Scandium (Sc3+) enhanced the levels of antibiotic
production by these strains bymultiple-fold when compared to the un-
treated sets. Pathway-speciﬁc antibiotic activator (actII-ORF4) tran-
scripts were upregulated in REE treated groups indicating the
activation of antibiotic production. The biosynthetic gene cluster for
actinorhodin production, which remained silent in S. lividans is highly
expressed upon treatment with Sc3+. This throws light on the applica-
bility of using REEs for expression of cryptic gene clusters. Although
the exact sites of action of REEs are unknown, it is thought that they
might bind to ribosomes (Kawai et al., 2007; Ochi et al., 2014; Zhu
et al., 2014). A study by Tanaka et al. (2010) showed that REEs (except
promethium (Pm)) enhanced the production of compound 4 in
S. coelicolor A3(2). Of these, the most effective ones were Sc3+ and
La3+, which altered the transcription of 17 genes belonging to 17 sec-
ondary metabolite biosynthetic gene clusters in S. coelicolor (Ochi and
Hosaka, 2013; Ochi et al., 2014; Tanaka et al., 2010).Supplementation of fermentation media with the solvent
dimethylsulfoxide (DMSO) elevated the levels of metabolites
from different biosynthetic families in Streptomyces sp. Three-fold
increases were achieved in the production of chloramphenicol
(63) by S. venezuelae ATCC 10712 and the polyketide
tetracenomycin C (64) by Streptomyces glaucescens. A two-fold in-
crease was observed in production of the peptide thiostrepton
(65) by Streptomyces azureus ATCC 14921 upon supplementation
with 3% (v/v) DMSO. DMSO has also been shown to enhance the
levels of prodigiosin (5) production by S. lividans. LC–MS analysis
revealed an alteration in the metabolite proﬁles of the antibiotic
producing Bacillus circulans and Bacillus polymyxa upon treatment
with DMSO, while ethanol enhanced the production of
tetracenomycin C by S. glaucescens but repressed chloramphenicol
production in S. venezuelae. Chloramphenicol production was in-
creased in the presence of dimethylsulfone (DMSN) but to a lesser
extent than that with DMSO (Chen et al., 2000; Pettit, 2011).Production of the pigmented benzoxazolophenanthridine antibiotic,
jadomycin B (66), in S. venezuelae ISP5230 in D-galactose-L-isoleucine
production medium was increased upon addition of ethanol. It was
speculated that ethanol either induces a heat shock response in
S. venezuelae ISP5230, serving as a metabolite precursor, or alters mem-
brane permeability (Doull et al., 1994; Pettit, 2011).4. Molecular elicitation
Apart from the cultivation-dependent elicitation approaches
mentioned above, the methods for identifying the metabolic prod-
ucts from silent gene clusters of microbes identiﬁed through geno-
mic mining has been reviewed (Challis, 2008). Mining microbial
genomes for identifying silent gene clusters and the subsequent
characterization of the cryptic products through gene-knock out
studies coupled with analytical techniques like HPLC–MS and
MALDI-TOF imaging, provides another platform to excavate the
hidden potential of actinomycetes (Müller and Wink, 2014).
New natural products encoded by silent gene clusters could be
unmasked by constitutive gene expression of putative regulators
present in the same gene cluster. For instance, constitutive overex-
pression of a pathway speciﬁc regulator protein (similar to Large
ATP binding of the LuxR, LAL) family that belonged to the cryptic
type I polyketide synthase (PKS) gene cluster in Streptomyces
ambofaciens ATCC 23877 directed the expression of four 51-
membered glycosylated macrolides, stambomycins A–D (67–70).
Stambomycins A–D (67–70) showed moderate antibacterial activ-
ity against Gram-positive bacteria and potent anti-proliferative ac-
tivities against human cell lines (Laureti et al., 2011; Ochi and
Hosaka, 2013; Ochi et al., 2014; Zhu et al., 2014).
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ble to deduce the natural products encoded from the orphan and si-
lent gene clusters; thus linking genes to the molecules that they
encode in-silico. Furthermore, applications of genetic engineering
and analytical tools to these cryptic gene clusters could validate
the in-silico predictions and characterize their products in-vitro.
Sequencing the genome of Streptomyces chattanoogensis L10 led
to identiﬁcation of twelve PKS gene clusters. The metabolic prod-
ucts of only two of these clusters have been identiﬁed. An
angucycline-like antibiotic, chattamycin biosynthetic gene cluster
was identiﬁed to be silent in S. chattanoogensis L10 and it was sub-
sequently activated by overexpression of the gene chaI encoding
the putative pathway-speciﬁc activator. This led to the identiﬁca-
tion of the angucycline antibiotics, chattamycins A and B (71–72)
(Zhou et al., 2015).
Twenty-nine cryptic gene clusters were identiﬁed in
Amycolatopsis japonicum using genome mining and one among
these was found to be a putative glycopeptide gene cluster. With
the aid of bioinformatic tools, ristomycin A (73), an antibacterial
and a diagnosis compound (used to detect hereditary diseases)
was postulated to be the possible product of this cluster. Genetic
manipulation of A. japonicum was done by introducing the bbr gene
(encoding the transcriptional activator of the glyopeptide balhimycin bio-
synthesis) from Amycolatopsis balhimycina (bbrAba) into A. japonicum.
Using LC-MS, MS/MS and NMR, it was conﬁrmed that genetically
engineered A. japonicum/pRM4-bbrAba produced ristomycin A (73) due
to the activation of cryptic ristomycin gene cluster (Spohn et al., 2014).
Thus genome mining combined with genetic manipulation techniques
could activate cryptic gene clusters in actinomycetes.
Bioinformatic analysis of the draft genome sequence of the ma-
rine actinomycete Saccharomonospora sp. CNQ490 revealed the di-
verse metabolic potential of this strain. A 67-kb (nonribosomal
peptide synthetase (NRPS)) tar gene cluster encoding taromycin
A (74) was identiﬁed to be silent in this strain. Transformation-
associated recombination cloning of this orphan biosyntheticgene cluster led to the subsequent activation of the gene cluster
with the production of dichlorinated lipopeptide antibiotic
taromycin A (74). Thus direct cloning and efﬁcient ‘plug-and-
play’ approaches could uncover the vast hidden genomic potential
in actinomycetes (Yamanaka et al., 2014).
Synthetic biology is an emerging strategy to awaken the crypticmet-
abolic gene clusters in actinomycetes. In this strategy, the identiﬁed si-
lent biosynthetic gene clusters are subjected to PCR-ampliﬁcation or
chemical synthesis followed by gene cluster reconstruction by selecting
suitable heterologous promoters. Once reconstructed, these gene clus-
ters are assembled in yeast and the assembled constructs isolated
from yeast are then re-transformed in E. coli and transferred to a heter-
ologous host after veriﬁcation of the assembled constructs. Application
of analytical techniques like LC–MS, MS/MS and NMR aids in detection
and characterization of the products from the heterologous host.
Employing this synthetic biology strategy led to the activation of cryptic
polycyclic tetramate macrolactam (PTM) biosynthetic gene cluster
SGR810-815 in S. griseus along with the discovery of three new PTMs
75–77 (Luo et al., 2013). Using a similar synthetic biology approach,
the silent spectinabilin pathway in Streptomyces orinoci was awakened
(Shao et al., 2013).
Ribosome engineering is a strain-improvement strategy adopted to
enhance the production of antibiotics by regulating the ribosomal compo-
nents (either the ribosomal proteins or rRNA). This involves introduction
ofmultiple drug resistantmutations in bacteria (since,majority of the an-
tibiotics target ribosomes) leading to high levels of antibiotic production,
which are predominantly due to the acquisition ofmutant ribosomes and
ppGpp (Guanosine tetraphosphate) synthesis activity, which is a keyme-
diator when bacteria encounter adverse environmental conditions such
as the limited availability of an essential nutrient (Wang et al., 2008).
Drug-resistant bacterial mutants isolated from soil have been shown to
synthesize antibacterial compounds piperidamycins A, D, and F (78–80),
whichwere lacking in thewild type. Activation of this class of compounds
was observed in 6% of the non-Streptomyces sp. and 43% of the Streptomy-
ces sp. among the 1068 soil-derived actinomycetes. Interestingly, all of the
antibacterial-producing, drug-resistant actinomycete mutants carried
mutations in the genes encoding RNA polymerase and/or the ribosomal
protein S12. Thus selection of drug resistant actinomycete mutants
could allow the discovery of new classes of antibacterial compounds
(Hosaka et al., 2009; Ochi and Hosaka, 2013).
Tanaka et al. used rifampin resistance (rpoB) mutations to activate
cryptic or poorly expressed secondary metabolite biosynthetic gene
clusters in various actinomycetes (Tanaka et al., 2013). The insertion
of certain rpoBmutations effectively increased antibiotic production in
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er), S. antibioticus (actinomycin producer), Streptomyces lavendulae
(formycin producer), Saccharopolyspora erythraea (erythromycin pro-
ducer), and Amycolatopsis orientalis (vancomycin producer).
Histone deacetylases (HDAC) alter chromatin structure and thus in-
ﬂuence the expression of biosynthetic gene clusters. Analysis for pres-
ence of histone deacetylase genes in S. coelicolor revealed the
existence of three HDAC-like genes. Evaluation on the effect of the
HDAC inhibitor, sodium butyrate, on antibiotic production in
S. coelicolor demonstrated a contrasting inﬂuence on actinorhoidin (4)
production. While sodium butyrate, similar to GlcNAc, upregulated the
production of compound 4 under poor nutrient conditions, an opposite
effect was observed under nutrient-rich conditions (Moore et al., 2012;
Zhu et al., 2014). The analogous effects of GlcNAc and sodium butyrate
on actinorhodin production suggest a common elicitation mechanism,
which is yet to be explored.
Olano et al. used three different genome mining-based approaches
to activate the expression of the silent gene clusters in S. albus J1074,
which is not known to produce any bioactive natural product under
standard growth conditions (Olano et al., 2014). After insertion of a
strong and constitutive promoter such as ermE*p (promoter of the
erythromycin resistance genes) in the front of selected genes of two
clusters, production of the blue pigment indigoidine (81) and of two
novel members of the polycyclic tetramate macrolactam family 6-epi-
alteramides A and B (82 and 83) was activated. Overexpression of pos-
itive regulatory genes from S. albus J1074 also activated the biosynthesis
of compounds 82 and 83 and heterologous expression of the regulatory
gene pimM (regulatory gene of the pimaricin pathway in S. natalensis)
activated the simultaneous production of candicidins and antimycins.A simple and effective method called reporter-guided mutant
selection (RGMS) was developed by Guo et al. (2015). This method
makes use of genome scale random mutagenesis for activation of
silent gene clusters and a promoter–reporter system for identiﬁcation
of the desired mutants based on speciﬁc phenotypes, indicating the ac-
tivation of transcription of the silent genes. RGMS re-activated the
jadomycin (66) production in S. venezuelae ISP5230 and also activated
the silent pga gene cluster in Streptomyces sp. PGA64 leading to the pro-
duction of the anthraquinone aminoglycosides gaudimycins D and E
(84–85). Thus suchplatforms thatmight generatemutations for activat-
ing the cryptic gene clusters coupled with speciﬁc reporter systems
might identify and characterize the products of the silent gene clusters.
From genome sequencing data of actinomycetes, it is evident that
those genomes encode a large potential of future drug leads.Classiﬁcation of gene clusters into families (GCFs) based on the available
sequence information andMS data provides an avenue for de novo cor-
relation of natural products and their corresponding biosynthetic genes.
A systematic bioinformatics framework was reported, which could be
used to study natural product gene clusters. Out of 830 bacterial ge-
nome sequences, 11,422 gene clusters were assigned into 4122 GCFs
and validated with MS data. Further, the assigned and unassigned
GCFswere linked to known natural products. Amethod of this type pro-
vides a roadmap to access the complete diversity of natural product
gene clusters in a systematic way (Doroghazi et al., 2014).
Genomic approaches coupled with metabolomics could prevent the
discovery of knownmetabolites fromactinomyceteswith the aid of spe-
ciﬁc de-replication strategies (Cimermancic et al., 2014; Harvey et al.,
2015; Gaudencio and Pereira, 2015; Letzel et al., 2013; Müller and
Wink, 2014; Tawﬁke et al., 2013). Using metabolomics, spectral data
from the samples could be processed by differential expression analysis
using software such asMZmine (Pluskal et al., 2010), MZmatch (Pluskal
et al., 2012) and XCMS (Tautenhahn et al., 2012) coupled with data-
bases such as Dictionary of Natural Products (Buckingham J. Dictionary
of Natural Products. Version 20:2. London, UK, Chapman and Hall/CRC,
2012), AntiBase (Laatsch H. Antibase Version 4.0 — The Natural Com-
pound Identiﬁer. Wiley-VCH Verlag GmbH & Co. KGaA, 2012) or
MarinLit (Blunt J. MarinLit. University of Canterbury, New Zealand,
2012) to differentiate known compounds against novel ones and LC-
1D/2D NMR data could help in conﬁrmation of these dereplication re-
sults (Dashti et al., 2014; Grkovic et al., 2014). Subjecting the
processed data generated by this way to principle component analysis
(PCA) and or orthogonal partial least squares discriminant analysis
(OPLS-DA) generates S-plots and heat maps (Krug and Müller, 2014;
Macintyre et al., 2014). Finally, with pattern recognition it is possible
to deﬁne novel natural products that could be further subjected to
scale-up efforts (Harvey et al., 2015; Krug and Müller, 2014). Chemical
structures of these natural products from the scale-up fermentation
studies could then be elucidated with analytical LC–MS-NMR spectral
data.
5. Conclusions and outlook
Actinomycetes are rich resources for natural products with dis-
crete pharmaceutical and biotechnological applications. The rapidly
growing number of actinomycete genome sequences reveals their
potential for biosynthesizing a plethora of secondary metabolites
that is much higher than the actual number of compounds produced
during classical fermentation. Subjecting the actinomycetes to mo-
lecular, biological, or chemical elicitation is an effective strategy to
provoke the expression of unexpressed or poorly expressed bioac-
tive metabolites and further, diversiﬁcation of secondary metabolite
proﬁles, thereby supplying novel drug leads to the natural products
based pharmaceutical pipeline. However, the lack of information
on the precise physiological and/or ecological signals to stimulate
the biosynthetic machinery makes the research on activating silent
gene clusters a challenging task, which requires interdisciplinary
strategies to activate them and to explore their full chemical diversi-
ty. This starts with the application of genomeminingwith the help of
bioinformatic algorithms such as antiSMASH (Blin et al., 2013) and
NapDoS (Ziemert et al., 2012) to identify the putative silent gene
clusters. The right elicitation approach to activate those cryptic path-
ways could be then identiﬁed using high throughput platform
(Seyedsayamdost, 2014; Zazopoulos et al., 2003). Efﬁcient
dereplication tools such as metabolomics and molecular networking
are then needed to avoid isolation of known compounds and to eval-
uate the possible novelty of the induced metabolites. Finally, struc-
tural identiﬁcation of the new cryptic products through LC–MS,
MS/MS and NMR will guide to the novel chemical scaffolds
(Doroghazi et al., 2014; Harvey et al., 2015; Kersten et al., 2011;
Krug and Müller, 2014). Besides, we posit that the natural
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will continue to hold promise for the future. Most of the elicitation
and mixed fermentation studies were carried out on actinomycetes
from terrestrial soils. The marine environment in particular offers
novel and chemically rich actinomycete species, which is still
underexplored in terms of elicitation and co-cultivation. Further-
more, challenging metabolically talented microorganisms with vari-
ous elicitors might be a successful approach to identify chemical
novelty. The required conceptual advancement would be aided by
the directed and coordinated datasets and that will ultimately reveal
the global regulatory networks (i.e., stress, starvation, quorum sens-
ing) into, which secondary metabolism is embedded. A multidisci-
plinary approach gathering the knowledge of molecular biologists,
natural products chemists, andmicrobiologists will enhance the elic-
itation pipeline towards production of valuable natural products for
pharmaceutical applications. Thus the identiﬁcation of cryptic gene
clusters by correlating genome mining and gene expression analyses
with elicitation approaches will provide a new avenue to the trea-
sure trove of natural products from actinomycetes.
Acknowledgements
Financial support to U.H. was provided by the Deutsche
Forschungsgemeinschaft (“SFB 630 TP A5”) and by the European
Commission within its FP7 Programme, under the thematic area
KBBE.2012.3.2-01 with Grant Number 311932 (“SeaBioTech”). S.B.
was supported by a fellowship of the German Excellence Initiative to
the Graduate School of Life Sciences, University of Würzburg.
References
Abdelmohsen, U.R., Bayer, K., Hentschel, U., 2014a. Diversity, abundance and natural
products of marine sponge-associated actinomycetes. Nat. Prod. Rep. 31, 381–399.
Abdelmohsen, U.R., Cheng, C., Viegelmann, C., Zhang, T., Grkovic, T., Ahmed, S., et al.,
2014b. Dereplication strategies for targeted isolation of new antitrypanosomal
actinosporins A and B from a marine sponge associated-Actinokineospora sp. EG49.
Mar. Drugs 12, 1220–1244.
Adegboye, M.F., Babalola, O.O., 2012. Taxonomy and ecology of antibiotic producing acti-
nomycetes. Afr. J. Agric. Res. 15, 2255–2261.
Anon., 2011. Streptomyces coelicolor increases the production of undecylprodigiosin when
interacted with Bacillus subtilis. Biotechnol. Lett. 33, 113–118.
Bader, J., Mast-Gerlach, E., Popovic, M.K., Bajpai, R., Stahl, U., 2010. Relevance of microbial
coculture fermentations in biotechnology. J. Appl. Microbiol. 109, 371–387.
Bajaj, I., Veiga, T., van Dissel, D., Pronk, J.T., Daran, J.M., 2014. Functional characterization
of a Penicillium chrysogenummutanase gene induced upon co-cultivation with Bacil-
lus subtilis. BMC Microbiol. 14.
Bentley, S.D., Chater, K.F., Cerdeno-Tarraga, A.M., Challis, G.L., Thomson, N.R., James, K.D.,
et al., 2002. Complete genome sequence of the model actinomycete Streptomyces
coelicolor A3(2). Nature 417, 141–147.
Blin, K., Medema, M.H., Kazempour, D., Fischbach, M.A., Breitling, R., Takano, E., et al.,
2013. antiSMASH 2.0—a versatile platform for genome mining of secondary metabo-
lite producers. Nucleic Acids Res. 41, W204–W212.
Bode, H.B., Bethe, B., Hofs, R., Zeeck, A., 2002. Big effects from small changes: possible
ways to explore nature's chemical diversity. Chembiochem 3, 619–627.
Brakhage, A.A., 2013. Regulation of fungal secondary metabolism. Nat. Rev. Microbiol. 11,
21–32.
Brakhage, A.A., Schroeckh, V., 2011. Fungal secondary metabolites— strategies to activate
silent gene clusters. Fungal Genit. Biol. 48, 15–22.
Caboche, S., 2014. Biosynthesis: bioinformatics bolster a renaissance. Nat. Chem. Biol. 10,
798–800.
Challis, G.L., 2008. Mining microbial genomes for new natural products and biosynthetic
pathways. Microbiology 154, 1555–1569.
Chen, G., Wang, G.Y., Li, X., Waters, B., Davies, J., 2000. Enhanced production of mi-
crobial metabolites in the presence of dimethyl sulfoxide. J. Antibiot. 53,
1145–1153.
Chiang, Y.M., Lee, K.H., Sanchez, J.F., Keller, N.P.,Wang, C.C., 2009. Unlocking fungal cryptic
natural products. Nat. Prod. Commun. 4, 1505–1510.
Chiang, Y.M., Chang, S.L., Oakley, B.R., Wang, C.C., 2011. Recent advances in awakening si-
lent biosynthetic gene clusters and linking orphan clusters to natural products in mi-
croorganisms. Curr. Opin. Chem. Biol. 15, 137–143.
Cimermancic, P., Medema, M.H., Claesen, J., Kurita, K., Brown, L.C.W., Mavrommatis, K., et
al., 2014. Insights into secondary metabolism from a global analysis of prokaryotic
biosynthetic gene clusters. Cell 158, 412–421.
Craney, A., Ozimok, C., Pimentel-Elardo, S.M., Capretta, A., Nodwell, J.R., 2012. Chemical
perturbation of secondary metabolism demonstrates important links to primary me-
tabolism. Chem. Biol. 19, 1020–1027.Dashti, Y., Grkovic, T., Abdelmohsen, U.R., Hentschel, U., Quinn, R.J., 2014. Produc-
tion of induced secondary metabolites by a co-culture of sponge-associated ac-
tinomycetes, Actinokineospora sp. EG49 and Nocardiopsis sp. RV163. Mar. Drugs
12, 3046–3059.
Doroghazi, J.R., Albright, J.C., Goering, A.W., Ju, K.S., Haines, R.R., Tchalukov, K.A., et al.,
2014. A roadmap for natural product discovery based on large-scale genomics and
metabolomics. Nat. Chem. Biol. 10, 963–968.
Doull, J.L., Singh, A.K., Hoare, M., Ayer, S.W., 1994. Conditions for the production of
jadomycin B by Streptomyces venezuelae ISP5230: effects of heat shock, ethanol treat-
ment and phage infection. J. Ind. Microbiol. 13, 120–125.
Even, S., Charlier, C., Nouaille, S., Zakour, N.L.B., Cretenet, M., Cousin, F.J., et al., 2009. Staph-
ylococcus aureus virulence expression is impaired by Lactococcus lactis in mixed cul-
tures. Appl. Environ. Microbiol. 75, 4459–4472.
Ezaki, M., Iwami, M., Yamashita, M., Komori, T., Umehara, K., Imanaka, H., 1992.
Biphenomycin A production by a mixed culture. Appl. Environ. Microbiol. 58,
3879–3882.
Ezaki, M., Shigematsu, N., Yamashita, M., Komori, T., Umehara, K., Imanaka, H., 1993.
Biphenomycin C, a precursor of biphenomycin A in mixed culture. J. Antibiot. 46,
135–140.
Fleming, A., 1929. On the antibacterial action of cultures of a Penicillium, with special ref-
erence to their use in the isolation of B. inﬂuenzae. Br. J. Exp. Pathol. 10, 222–236.
Galet, J., Deveau, A., Hotel, L., Leblond, P., Frey-Klett, P., Aigle, B., 2014. Gluconic acid-
producing Pseudomonas sp. prevent gamma-actinorhodin biosynthesis by Streptomy-
ces coelicolor A3(2). Arch. Microbiol. 196, 619–627.
Gaudencio, S.P., Pereira, F., 2015. Dereplication: racing to speed up the natural products
discovery process. Nat. Prod. Rep. 32, 779–810.
Grkovic, T., Pouwer, R.H., Vial, M.L., Gambini, L., Noel, A., Hooper, J.N.A., et al., 2014.
NMR ﬁngerprints of the drug-like natural-product space identify iotrochotazine
A: a chemical probe to study Parkinson's disease. Angew. Chem. Int. Ed. 53,
6070–6074.
Gross, H., 2009. Genomic mining—a concept for the discovery of new bioactive natural
products. Curr. Opin. Drug Discov. Dev. 12, 207–219.
Guo, F., Xiang, S., Li, L., Wang, B., Rajasarkka, J., Grondahl-Yli-Hannuksela, K., et al., 2015.
Targeted activation of silent natural product biosynthesis pathways by reporter-
guided mutant selection. Metab. Eng. 28, 134–142.
Harvey, A.L., Edrada-Ebel, R., Quinn, R.J., 2015. The re-emergence of natural products for
drug discovery in the genomics era. Nat. Rev. Drug Discov. 14, 111–129.
Hertweck, C., 2009. Hidden biosynthetic treasures brought to light. Nat. Chem. Biol. 5,
450–452.
Ho, T.F., Ma, C.J., Lu, C.H., Tsai, Y.T., Wei, Y.H., Chang, J.S., et al., 2007. Undecylprodigiosin
selectively induces apoptosis in human breast carcinoma cells independent of p53.
Toxicol. Appl. Pharmacol. 225, 318–328.
Hopwood, D.A., 2007. Therapeutic treasures from the deep. Nat. Chem. Biol. 3, 457–458.
Hosaka, T., Ohnishi-Kameyama, M., Muramatsu, H., Murakami, K., Tsurumi, Y., Kodani, S.,
et al., 2009. Antibacterial discovery in actinomycetes strains with mutations in RNA
polymerase or ribosomal protein S12. Nat. Biotechnol. 27, 462–464.
Imai, Y., Sato, S., Tanaka, Y., Ochi, K., Hosaka, T., 2015. Lincomycin at subinhibitory concen-
trations potentiates secondary metabolite production by Streptomyces spp. Appl. En-
viron. Microbiol. 81, 3869–3879.
Isaka, M., Boonkhao, B., Rachtawee, P., Auncharoen, P., 2007. A xanthocillin-like alkaloid
from the insect pathogenic fungus Cordyceps brunnearubra BCC 1395. J. Nat. Prod.
70, 656–658.
Jensen, P.R., Chavarria, K.L., Fenical, W., Moore, B.S., Ziemert, N., 2014. Challenges and tri-
umphs to genomics-based natural product discovery. J. Ind. Microbiol. Biotechnol. 41,
203–209.
Kawai, K., Wang, G., Okamoto, S., Ochi, K., 2007. The rare earth, scandium, causes antibi-
otic overproduction in Streptomyces spp. FEMS Microbiol. Lett. 274, 311–315.
Kersten, R.D., Yang, Y.L., Xu, Y., Cimermancic, P., Nam, S.J., Fenical, W., et al., 2011. A mass
spectrometry-guided genome mining approach for natural product
peptidogenomics. Nat. Chem. Biol. 7, 794–802.
König, C.C., Scherlach, K., Schroeckh, V., Horn, F., Nietzsche, S., Brakhage, A.A., et al., 2013.
Bacterium induces crypticmeroterpenoid pathway in the pathogenic fungus Aspergil-
lus fumigatus. Chembiochem 14, 938–942.
Krug, D., Müller, R., 2014. Secondary metabolomics: the impact of mass spectrometry-
based approaches on the discovery and characterization of microbial natural prod-
ucts. Nat. Prod. Rep. 31, 768–783.
Krug, D., Zurek, G., Revermann, O., Vos, M., Velicer, G.J., Müller, R., 2008. Discovering the
hidden secondary metabolome ofMyxococcus xanthus: a study of intraspeciﬁc diver-
sity. Appl. Environ. Microbiol. 74, 3058–3068.
Kurosawa, K., Ghiviriga, I., Sambandan, T.G., Lessard, P.A., Barbara, J.E., Rha, C., et al.,
2008. Rhodostreptomycins, antibiotics biosynthesized following horizontal
gene transfer from Streptomyces padanus to Rhodococcus fascians. J. Am. Chem.
Soc. 130, 1126–1127.
Laureti, L., Song, L., Huang, S., Corre, C., Leblond, P., Challis, G.L., et al., 2011. Identiﬁcation
of a bioactive 51-membered macrolide complex by activation of a silent polyketide
synthase in Streptomyces ambofaciens. Proc. Natl. Acad. Sci. U. S. A. 108, 6258–6263.
Letzel, A.C., Pidot, S.J., Hertweck, C., 2013. A genomic approach to the cryptic secondary
metabolome of the anaerobic world. Nat. Prod. Rep. 30, 392–428.
Li, J.W., Vederas, J.C., 2009. Drug discovery and natural products: end of an era or an end-
less frontier? Science 325, 161–165.
Luo, Y., Huang, H., Liang, J., Wang, M., Lu, L., Shao, Z., et al., 2013. Activation and character-
ization of a cryptic polycyclic tetramate macrolactam biosynthetic gene cluster. Nat.
Commun. 4, 2894.
Luti, K.J., Mavituna, F., 2011. Elicitation of Streptomyces coelicolorwith dead cells of Bacillus
subtilis and Staphylococcus aureus in a bioreactor increases production of
undecylprodigiosin. Appl. Microbiol. Biotechnol. 90, 461–466.
811U.R. Abdelmohsen et al. / Biotechnology Advances 33 (2015) 798–811Macintyre, L., Zhang, T., Viegelmann, C., Martinez, I.J., Cheng, C., Dowdells, C., et al., 2014.
Metabolomic tools for secondary metabolite discovery frommarine microbial symbi-
onts. Mar. Drugs 12, 3416–3448.
Marmann, A., Aly, A.H., Lin, W., Wang, B., Proksch, P., 2014. Co-cultivation—a powerful
emerging tool for enhancing the chemical diversity of microorganisms. Mar. Drugs
12, 1043–1065.
Moody, S.C., 2014. Microbial co-culture: harnessing intermicrobial signaling for the pro-
duction of novel antimicrobials. Future Microbiol 9, 575–578.
Moore, J.M., Bradshaw, E., Seipke, R.F., Hutchings, M.I., McArthur, M., 2012. Use and dis-
covery of chemical elicitors that stimulate biosynthetic gene clusters in Streptomyces
bacteria. Methods Enzymol. 517, 367–385.
Müller, R., Wink, J., 2014. Future potential for anti-infectives from bacteria — how to ex-
ploit biodiversity and genomic potential. Int. J. Med. Microbiol. 304, 3–13.
Murphy, T.M., Nilsson, A.Y., Roy, I., Harrop, A., Dixon, K., Keshavarz, T., 2011. Enhanced in-
tracellular Ca2+ concentrations in Escherichia coli and Bacillus subtilis after addition of
oligosaccharide elicitors. Biotechnol. Lett. 33, 985–991.
Nair, R., Roy, I., Bucke, C., Keshavarz, T., 2009. Quantitative PCR study on the mode of ac-
tion of oligosaccharide elicitors on penicillin G production by Penicillium
chrysogenum. J. Appl. Microbiol. 107, 1131–1139.
Nett, M., Ikeda, H., Moore, B.S., 2009. Genomic basis for natural product biosynthetic di-
versity in the actinomycetes. Nat. Prod. Rep. 26, 1362–1384.
Nouaille, S., Even, S., Charlier, C., Le Loir, Y., Cocaign-Bousquet, M., Loubiere, P., 2009.
Transcriptomic response of Lactococcus lactis in mixed culture with Staphylococcus
aureus. Appl. Environ. Microbiol. 75, 4473–4482.
Nützmann, H.W., Reyes-Dominguez, Y., Scherlach, K., Schroeckh, V., Horn, F., Gacek, A., et
al., 2011. Bacteria-induced natural product formation in the fungus Aspergillus
nidulans requires Saga/Ada-mediated histone acetylation. Proc. Natl. Acad. Sci. U. S.
A. 108, 14282–14287.
Ochi, K., Hosaka, T., 2013. New strategies for drug discovery: activation of silent or weakly
expressed microbial gene clusters. Appl. Microbiol. Biotechnol. 97, 87–98.
Ochi, K., Okamoto, S., 2012. A magic bullet for antibiotic discovery. Chem. Biol. 19, 932–934.
Ochi, K., Tanaka, Y., Tojo, S., 2014. Activating the expression of bacterial cryptic genes by
rpoB mutations in RNA polymerase or by rare earth elements. J. Ind. Microbiol.
Biotechnol. 41, 403–414.
Oh, D.C., Kauffman, C.A., Jensen, P.R., Fenical, W., 2007. Induced production of
emericellamides A and B from themarine-derived fungus Emericella sp. in competing
co-culture. J. Nat. Prod. 70, 515–520.
Ola, A.R., Thomy, D., Lai, D., Brötz-Oesterhelt, H., Proksch, P., 2013. Inducing secondary
metabolite production by the endophytic fungus Fusarium tricinctum through cocul-
ture with Bacillus subtilis. J. Nat. Prod. 76, 2094–2099.
Olano, C., Garcia, I., Gonzalez, A., Rodriguez, M., Rozas, D., Rubio, J., et al., 2014. Activation
and identiﬁcation of ﬁve clusters for secondary metabolites in Streptomyces albus
J1074. Microb. Biotechnol. 7, 242–256.
Onaka, H., Mori, Y., Igarashi, Y., Furumai, T., 2011. Mycolic acid-containing bacteria induce
natural-product biosynthesis in Streptomyces species. Appl. Environ. Microbiol. 77,
400–406.
Paranagama, P.A., Wijeratne, E.M.K., Gunatilaka, A.A.L., 2007. Uncovering biosynthetic po-
tential of plant-associated fungi: effect of culture conditions on metabolite produc-
tion by Paraphaeosphaeria quadriseptata and Chaetomium chiversii. J. Nat. Prod. 70,
1939–1945.
Perez, J., Munoz-Dorado, J., Brana, A.F., Shimkets, L.J., Sevillano, L., Santamaria, R.I., 2011.
Myxococcus xanthus induces actinorhodin overproduction and aerial mycelium for-
mation by Streptomyces coelicolor. Microb. Biotechnol. 4, 175–183.
Pettit, R.K., 2011. Small-molecule elicitation of microbial secondary metabolites. Microb.
Biotechnol. 4, 471–478.
Pluskal, T., Castillo, S., Villar-Briones, A., Oresic, M., 2010. MZmine 2: modular framework
for processing, visualizing, and analyzing mass spectrometry-based molecular proﬁle
data. BMC Bioinform. 11, 395.
Pluskal, T., Uehara, T., Yanagida, M., 2012. Highly accurate chemical formula prediction
tool utilizing high-resolution mass spectra, MS/MS fragmentation, Heuristic rules,
and isotope pattern matching. Anal. Chem. 84, 4396–4403.
Radman, R., Saez, T., Bucke, C., Keshavarz, T., 2003. Elicitation of plants and microbial cell
systems. Biotechnol. Appl. Biochem. 37, 91–102.
Radman, R., Bland, E.J., Sangworachat, N., Bucke, C., Keshavarz, T., 2006. Effects of oligosac-
charides and polysaccharides on the generation of reactive oxygen species in differ-
ent biological systems. Biotechnol. Appl. Biochem. 44, 129–133.
Rateb, M.E., Hallyburton, I., Houssen, W.E., Bull, A.T., Goodfellow, M., Santhanam, R., et al.,
2013. Induction of diverse secondary metabolites in Aspergillus fumigatus bymicrobi-
al co-culture. RSC Adv. 3, 14444–14450.
Recio, E., Colinas, A., Rumbero, A., Aparicio, J.F., Martin, J.F., 2004. PI factor, a novel type
quorum-sensing inducer elicits pimaricin production in Streptomyces natalensis.
J. Biol. Chem. 279, 41586–41593.
Recio, E., Aparicio, J.F., Rumbero, A., Martin, J.F., 2006. Glycerol, ethylene glycol and
propanediol elicit pimaricin biosynthesis in the PI-factor-defective strain Streptomy-
ces natalensis npi287 and increase polyene production in several wild-type actinomy-
cetes. Microbiology 152, 3147–3156.Rigali, S., Titgemeyer, F., Barends, S., Mulder, S., Thomae, A.W., Hopwood, D.A., et al., 2008.
Feast or famine: the global regulator DasR links nutrient stress to antibiotic produc-
tion by Streptomyces. EMBO Rep. 9, 670–675.
Romero, D., de Vicente, A., Rakotoaly, R.H., Dufour, S.E., Veening, J.W., Arrebola, E., et al.,
2007. The iturin and fengycin families of lipopeptides are key factors in antagonism
of Bacillus subtilis toward Podosphaera fusca. Mol. PlantMicrobe Interact. 20, 430–440.
Schäberle, T.F., Orland, A., König, G.M., 2014. Enhanced production of undecylprodigiosin
in Streptomyces coelicolor by co-cultivation with the corallopyronin A-producing
myxobacterium, Corallococcus coralloides. Biotechnol. Lett. 36, 641–648.
Schroeckh, V., Scherlach, K., Nützmann, H.W., Shelest, E., Schmidt-Heck, W., Schuemann,
J., et al., 2009. Intimate bacterial–fungal interaction triggers biosynthesis of archetyp-
al polyketides in Aspergillus nidulans. Proc. Natl. Acad. Sci. U. S. A. 106, 14558–14563.
Seyedsayamdost, M.R., 2014. High-throughput platform for the discovery of elicitors of si-
lent bacterial gene clusters. Proc. Natl. Acad. Sci. U. S. A. 111, 7266–7271.
Shao, Z., Rao, G., Li, C., Abil, Z., Luo, Y., Zhao, H., 2013. Refactoring the silent spectinabilin
gene cluster using a plug-and-play scaffold. ACS Synth. Biol. 2, 662–669.
Slattery, M., Rajbhandari, I., Wesson, K., 2001. Competition-mediated antibiotic induction
in the marine bacterium Streptomyces tenjimariensis. Microb. Ecol. 41, 90–96.
Spohn, M., Kirchner, N., Kulik, A., Jochim, A., Wolf, F., Muenzer, P., et al., 2014. Overproduc-
tion of Ristomycin A by activation of a silent gene cluster in Amycolatopsis japonicum
MG417-CF17. Antimicrob. Agents Chemother. 58, 6185–6196.
Tanaka, Y., Hosaka, T., Ochi, K., 2010. Rare earth elements activate the secondary
metabolite-biosynthetic gene clusters in Streptomyces coelicolor A3(2). J. Antibiot.
63, 477–481.
Tanaka, Y., Kasahara, K., Hirose, Y., Murakami, K., Kugimiya, R., Ochi, K., 2013. Activation
and products of the cryptic secondarymetabolite biosynthetic gene clusters by rifam-
pin resistance (rpoB) mutations in actinomycetes. J. Bacteriol. 195, 2959–2970.
Tautenhahn, R., Patti, G.J., Rinehart, D., Siuzdak, G., 2012. XCMS Online: A web-based plat-
form to process untargeted metabolomic data. Anal. Chem. 84, 5035–5039.
Tawﬁke, A.F., Viegelmann, C., Edrada-Ebel, R., 2013. Metabolomics and dereplication
strategies in natural products. Methods Mol. Biol. 1055, 227–244.
Traxler, M.F., Watrous, J.D., Alexandrov, T., Dorrestein, P.C., Kolter, R., 2013. Interspecies
interactions stimulate diversiﬁcation of the Streptomyces coelicolor secreted metabo-
lome. mBio 4.
Ueda, K., Kawai, S., Ogawa, H., Kiyama, A., Kubota, T., Kawanobe, H., et al., 2000. Wide dis-
tribution of interspeciﬁc stimulatory events on antibiotic production and sporulation
among Streptomyces species. J. Antibiot. 53, 979–982.
Van Lanen, S.G., Shen, B., 2006. Microbial genomics for the improvement of natural prod-
uct discovery. Curr. Opin. Microbiol. 9, 252–260.
Wang, G., Hosaka, T., Ochi, K., 2008. Dramatic activation of antibiotic production in Strep-
tomyces coelicolor by cumulative drug resistance mutations. Appl. Environ. Microbiol.
74, 2834–2840.
Wang, D., Yuan, J., Gu, S., Shi, Q., 2013. Inﬂuence of fungal elicitors on biosynthesis of
natamycin by Streptomyces natalensis/HW-2. Appl. Microbiol. Biotechnol. 97,
5527–5534.
Waters, C.M., Bassler, B.L., 2005. Quorum sensing: cell-to-cell communication in bacteria.
Annu. Rev. Cell Dev. Biol. 21, 319–346.
Watve, M.G., Tickoo, R., Jog, M.M., Bhole, B.D., 2001. How many antibiotics are produced
by the genus Streptomyces? Arch. Microbiol. 176, 386–390.
Wei, H., Lin, Z., Li, D., Gu, Q., Zhu, T., 2010. OSMAC (one strain many compounds) ap-
proach in the research ofmicrobial metabolites. Wei ShengWu Xue Bao 50, 701–709.
Wenzel, S.C., Müller, R., 2009. The biosynthetic potential ofmyxobacteria and their impact
in drug discovery. Curr. Opin. Drug Discov. Dev. 12, 220–230.
Williamson, N.R., Fineran, P.C., Leeper, F.J., Salmond, G.P., 2006. The biosynthesis and reg-
ulation of bacterial prodiginines. Nat. Rev. Microbiol. 4, 887–899.
Yamanaka, K., Oikawa, H., Ogawa, H.O., Hosono, K., Shinmachi, F., Takano, H., et al., 2005.
Desferrioxamine E produced by Streptomyces griseus stimulates growth and develop-
ment of Streptomyces tanashiensis. Microbiology 151, 2899–2905.
Yamanaka, K., Reynolds, K.A., Kersten, R.D., Ryan, K.S., Gonzalez, D.J., Nizet, V., et al., 2014.
Direct cloning and refactoring of a silent lipopeptide biosynthetic gene cluster yields
the antibiotic taromycin A. Proc. Natl. Acad. Sci. U. S. A. 111, 1957–1962.
Zazopoulos, E., Huang, K., Staffa, A., Liu, W., Bachmann, B.O., Nonaka, K., et al., 2003. A
genomics-guided approach for discovering and expressing cryptic metabolic path-
ways. Nat. Biotechnol. 21, 187–190.
Zhou, Z., Xu, Q., Bu, Q., Guo, Y., Liu, S., Liu, Y., et al., 2015. Genomemining-directed activa-
tion of a silent angucycline biosynthetic gene cluster in Streptomyces chattanoogensis.
Chembiochem 16, 496–502.
Zhu, H., Sandiford, S.K., van Wezel, G.P., 2014. Triggers and cues that activate antibiotic
production by actinomycetes. J. Ind. Microbiol. Biotechnol. 41, 371–386.
Ziemert, N., Podell, S., Penn, K., Badger, J.H., Allen, E., Jensen, P.R., 2012. The natural prod-
uct domain seeker NaPDoS: a phylogeny based bioinformatic tool to classify second-
ary metabolite gene diversity. PLoS One 7, e34064.
Zuck, K.M., Shipley, S., Newman, D.J., 2011. Induced production of N-formyl alkaloids from
Aspergillus fumigatus by co-culture with Streptomyces peucetius. J. Nat. Prod. 74,
1653–1657.
